Cetera Investment Advisers
ALNY icon

Cetera Investment Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Cetera Investment Advisers’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.98M Buy
23,196
+23
+0.1% +$6.94K 0.01% 1373
2026
Q1 		$7.67M Buy
23,173
+5,624
+32% +$1.91M 0.01% 1233
2025
Q4 		$6.98M Buy
17,549
+3,026
+21% +$1.34M 0.01% 1243
2025
Q3 		$6.62M Buy
14,523
+4,635
+47% +$1.89M 0.01% 1215
2025
Q2 		$3.22M Buy
9,888
+1,871
+23% +$518K 0.01% 1495
2025
Q1 		$2.16M Buy
8,017
+3,247
+68% +$834K ﹤0.01% 1693
2024
Q4 		$1.12M Buy
4,770
+1,902
+66% +$500K ﹤0.01% 2086
2024
Q3 		$789K Buy
2,868
+129
+5% +$33.6K ﹤0.01% 2290
2024
Q2 		$666K Sell
2,739
-819
-23% -$129K ﹤0.01% 2375
2024
Q1 		$532K Buy
3,558
+2,388
+204% +$398K ﹤0.01% 2558
2023
Q4 		$224K Buy
+1,170
New +$199K ﹤0.01% 1977
2023
Q2 		– Sell
-1,187
Closed -$238K – 2196
2023
Q1 		$238K Buy
1,187
+24
+2% +$5.04K ﹤0.01% 1839
2022
Q4 		$276K Buy
+1,163
New +$248K ﹤0.01% 1715
2022
Q1 		– Sell
-1,217
Closed -$206K – 1873
2021
Q4 		$206K Buy
+1,217
New +$226K ﹤0.01% 1721

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Investment Advisers's ALNY Position: Q2 2026 in Review

Cetera Investment Advisers increased its Alnylam Pharmaceuticals (ALNY) stake by 0.1% in Q2 2026, buying an estimated $6.94K and bringing the position to 23,196 shares worth $6.98M. The position accounts for 0.01% of the portfolio, ranked #1373.

Cetera Investment Advisers first reported a position in ALNY in Q4 2021 and has held it in 14 quarters since. The position peaked at $7.67M in Q1 2026. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Cetera Investment Advisers held 23,196 shares of Alnylam Pharmaceuticals worth $6.98M as of Q2 2026.
  • Cetera Investment Advisers bought 23 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $6.94K.
  • Alnylam Pharmaceuticals made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1373 holding.
  • Cetera Investment Advisers first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • Cetera Investment Advisers's Alnylam Pharmaceuticals position peaked at $7.67M in Q1 2026.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.